Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)
Clinical trial NCT00623103 · COMPLETED
Trial details
- NCT number
- NCT00623103
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2010-11-01
- Enrollment
- 583
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.